| International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations DH Barouch, SV Kik, GJ Weverling, R Dilan, SL King, LF Maxfield, S Clark, ... Vaccine 29 (32), 5203-5209, 2011 | 335 | 2011 |
| Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ... PLoS pathogens 12 (1), e1005369, 2016 | 278 | 2016 |
| Standardization of cytokine flow cytometry assays HT Maecker, A Rinfret, P D'Souza, J Darden, E Roig, C Landry, P Hayes, ... BMC immunology 6, 1-18, 2005 | 277 | 2005 |
| CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa E Karita, N Ketter, MA Price, K Kayitenkore, P Kaleebu, A Nanvubya, ... PloS one 4 (2), e4401, 2009 | 205 | 2009 |
| Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection OA Anzala, NJD Nagelkerke, JJ Bwayo, D Holton, S Moses, EN Ngugi, ... Journal of Infectious Diseases 171 (3), 686-689, 1995 | 188 | 1995 |
| Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers G Mutua, E Sanders, P Mugo, O Anzala, JE Haberer, D Bangsberg, ... PloS one 7 (4), e33103, 2012 | 180 | 2012 |
| Recombination following superinfection by HIV-1 G Fang, B Weiser, C Kuiken, SM Philpott, S Rowland-Jones, F Plummer, ... Aids 18 (2), 153-159, 2004 | 166 | 2004 |
| Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa MA Price, CL Wallis, S Lakhi, E Karita, A Kamali, O Anzala, EJ Sanders, ... AIDS research and human retroviruses 27 (1), 5-12, 2011 | 152 | 2011 |
| Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth MA Price, W Rida, M Mwangome, G Mutua, K Middelkoop, S Roux, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), 185-193, 2012 | 145 | 2012 |
| Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa E Karita, M Price, E Hunter, E Chomba, S Allen, L Fei, A Kamali, ... Aids 21 (4), 403-408, 2007 | 145 | 2007 |
| Early antibody lineage diversification and independent limb maturation lead to broad HIV-1 neutralization targeting the Env high-mannose patch DT MacLeod, NM Choi, B Briney, F Garces, LS Ver, E Landais, B Murrell, ... Immunity 44 (5), 1215-1226, 2016 | 133 | 2016 |
| IL‐7Rα expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation SA Koesters, JB Alimonti, C Wachihi, L Matu, O Anzala, J Kimani, ... European journal of immunology 36 (2), 336-344, 2006 | 133 | 2006 |
| Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa PN Amornkul, E Karita, A Kamali, WN Rida, EJ Sanders, S Lakhi, ... Aids 27 (17), 2775-2786, 2013 | 117 | 2013 |
| Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa W Jaoko, E Karita, K Kayitenkore, G Omosa-Manyonyi, S Allen, S Than, ... PloS one 5 (9), e12873, 2010 | 114 | 2010 |
| Safety and immunogenicity of a 2-dose heterologous vaccine regimen with Ad26. ZEBOV and MVA-BN-Filo Ebola vaccines: 12-month data from a phase 1 randomized clinical trial in … G Mutua, O Anzala, K Luhn, C Robinson, V Bockstal, D Anumendem, ... The Journal of infectious diseases 220 (1), 57-67, 2019 | 108 | 2019 |
| Bombali virus in Mops condylurus bat, Kenya KM Forbes, PW Webala, AJ Jääskeläinen, S Abdurahman, J Ogola, ... Emerging Infectious Diseases 25 (5), 955, 2019 | 106 | 2019 |
| Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa W Jaoko, FN Nakwagala, O Anzala, GO Manyonyi, J Birungi, A Nanvubya, ... Vaccine 26 (22), 2788-2795, 2008 | 105 | 2008 |
| Identification of preferential CD4+ T-cell targets for HIV infection in the cervix VR Joag, LR McKinnon, J Liu, ST Kidane, MH Yudin, B Nyanga, ... Mucosal immunology 9 (1), 1-12, 2016 | 92 | 2016 |
| Assessment of the safety and immunogenicity of 2 novel vaccine platforms for HIV-1 prevention: a randomized trial LR Baden, E Karita, G Mutua, LG Bekker, G Gray, L Page-Shipp, ... Annals of internal medicine 164 (5), 313-322, 2016 | 89 | 2016 |
| Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates A Spentzou, P Bergin, D Gill, H Cheeseman, A Ashraf, H Kaltsidis, ... The Journal of infectious diseases 201 (5), 720-729, 2010 | 85 | 2010 |
